(2,2,2-Trifluoroethyl)benzene

Catalog No.: 
ACFPXK950
CAS No.: 
21249-93-4
Molecular Formula: 
C8H7F3
Molecular Weight: 
160.14
(2,2,2-Trifluoroethyl)benzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$117.00InquiryInquiry
1g97%$254.00InquiryInquiry
5g97%$956.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2,2,2-Trifluoroethyl)benzene
IUPAC Name(2,2,2-trifluoroethyl)benzene
MDL No.T168560
Molecular FormulaC8H7F3
Molecular Weight160.14
SMILESFC(F)(F)CC1=CC=CC=C1
InChI KeyAVSVJSGDSPDFLH-UHFFFAOYSA-N
Synonym(2,2,2-trifluoroethyl)benzene | 21249-93-4 | 2,2,2-trifluoroethylbenzene | Benzene, (2,2,2-trifluoroethyl)- | NSC142238 | 3-tri-fluoroethylbenzene | SCHEMBL185769 | Benzene, 2,2,2-trifluoroethyl | DTXSID30301294 | PFSGUFYCNKITHK-UHFFFAOYSA-N | (2,2,2-Trifluoro-ethyl)-benzene
CAS No.21249-93-4
PubChem CID285373

Synthetic Route by SureRoute

1. ACFPXK950 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAZKW940 route compound structure diagram
    ACAZKW940340-05-6In Stock
  2. Then
  3. ACFPXK950 route product structure diagram
    ACFPXK95021249-93-4
Inquiry

2. ACFPXK950 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACFPXK950 route product structure diagram
    ACFPXK95021249-93-4
Inquiry

3. ACFPXK950 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACFPXK950 route product structure diagram
    ACFPXK95021249-93-4
Inquiry

Comments (0)